Why Receptor Signaling Changes During Continued Stimulation

Activated GPCRs can be phosphorylated by G protein-coupled receptor kinases. Arrestins may bind phosphorylated receptors, reduce further G-protein coupling, and connect receptors with endocytic or signaling machinery. The pattern depends on receptor sequence, ligand, kinase expression, phosphorylation sites, and cell type. Arrestin recruitment in a reporter assay is evidence for one interaction, not proof of the complete trafficking fate in native tissue.

Endocytosed receptors enter compartments that sort them toward rapid recycling, slower recycling, lysosomal degradation, or other routes. Some continue signaling from endosomes, creating spatially distinct outputs. Ligand dissociation, dephosphorylation, ubiquitination, and accessory proteins influence fate. Measuring loss from the plasma membrane at one time point cannot distinguish temporary sequestration from long-term downregulation.

Reduced response in an organism can arise from receptor regulation, altered exposure, counter-regulatory physiology, disease progression, learning, measurement change, or other mechanisms. Cellular internalization data alone cannot identify the cause. Strong interpretation combines ligand concentrations, receptor occupancy, signaling, trafficking, pharmacokinetics, and functional outcomes over time. This page offers no protocol or advice for manipulating receptor responsiveness.

Recovery experiments add useful separation. Removing ligand and following surface receptor, pathway response, and protein abundance can distinguish rapid resensitization from slower receptor replacement. The result still remains specific to the receptor, cell system, exposure pattern, and measured pathway.